首药控股 (688197)
Shouyao Holdings (Beijing) Co., Ltd.
K-Line Chart
No K-line data available
Company NameShouyao Holdings (Beijing) Co., Ltd.
Listing Date2022-03-23
Issue Price39.9RMB
Registered Capital14871.934310k RMB
Legal RepresentativeLi Wenjun
Registered AddressUnit 2202-2, 19th Floor, Building 1, No. 10 Ronghua Middle Road, Beijing Economic-Technological Development Area, Beijing
IndustryChemical Pharmaceuticals
Main BusinessThe company is a small-molecule innovative drug enterprise in the clinical research stage. Its R&D pipeline covers key oncology indications such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, thyroid cancer, ovarian cancer, leukemia, as well as other important disease areas including type II diabetes.
Company ProfileShouyao Holdings (Beijing) Co., Ltd. adheres to the business philosophy of 'developing first-class new drugs affordable for Chinese patients', focusing on new drug R&D and committed to enhancing the international status of China's innovative drugs. After years of development, the company has achieved significant results in the field of anti-tumor innovative drugs, obtaining 110 invention patents globally. Its R&D pipeline comprises 23 projects, all of which are Class 1 new drugs, including 11 fully self-developed and 12 co-developed (the company is responsible for discovering candidate drugs, with partners conducting clinical research and commercialization). Among the self-developed projects, one product has entered Phase II/III clinical trials, one has entered Phase II clinical trials, one has entered Phase I clinical trials, and three have submitted clinical trial applications to the CDE and been accepted. Among the co-developed projects, one product has entered Phase II/III clinical trials, one has entered Phase II clinical trials, and eight have entered Phase I clinical trials.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Automobile Co., Ltd.
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Innovation Group as the main sponsor....
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Penghua Pharmaceutical Technology Equity Securities Investment Fund Class A | Public Fund | 540.79 | 8.45 |
| 2 | Beijing Shuanglu Pharmaceutical Co., Ltd. | Corporate Legal Person | 526.32 | 8.22 |
| 3 | National Social Security Fund 413 Portfolio | Social Security Fund | 263.70 | 4.12 |
| 4 | Beijing Yizhuang International Investment Development Co., Ltd. | Corporate Legal Person | 204.90 | 3.20 |
| 5 | Beijing Chengzexin Technology Development Center (Limited Partnership) | Corporate Legal Person | 175.32 | 2.74 |
| 6 | Beijing Wangenxian Technology Development Center (Limited Partnership) | Corporate Legal Person | 148.54 | 2.32 |
| 7 | Penghua Innovation Upgrade Hybrid Securities Investment Fund Class A | Public Fund | 76.82 | 1.20 |
| 8 | Penghua Healthcare Equity Securities Investment Fund | Public Fund | 58.81 | 0.92 |
| 9 | Penghua Pension Industry Equity Securities Investment Fund | Public Fund | 53.07 | 0.83 |
| 10 | Penghua Innovation Growth One-Year Holding Hybrid Securities Investment Fund Class A | Public Fund | 16.14 | 0.25 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicle
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-09-30
- Data source: Public market information